Maaike P.G. Vreeswijk

An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

Oded Kopper, Chris J. de Witte, Kadi Lõhmussaar et al. · Nature Medicine · 2019 · 796 citations

Tumor Biology, Endocrine Oncology, Medicine +9

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Stefanie de Groot, Rieneke T. Lugtenberg, Danielle Cohen et al. · Nature Communications · 2020 · 320 citations · Full text

The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

Stefanie de Groot, Maaike P.G. Vreeswijk, Marij J.P. Welters et al. · BMC Cancer · 2015 · 242 citations · Full text

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

Antonis C. Antoniou, Olga M. Sinilnikova, Jacques Simard et al. · The American Journal of Human Genetics · 2007 · 242 citations · Full text

Genome Instability, Breast Oncology, Brca2 Mutation Carriers +11

Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial Rosai-Dorfman Disease

Neil V. Morgan, Mark R. Morris, Hakan Cangül et al. · PLoS Genetics · 2010 · 222 citations · Full text

Genetics, Pathology, Molecular Genetics +16